Merdeka.com – The government is boosting the production of red and white vaccines. Director General of Pharmaceutical Chemical and Textile Industry (IKFT) of the Ministry of Industry, Muhammad Khayam said clinical trials on humans will be carried out in the near future.
Referring to the timeline for the production of the red and white vaccine by Universitas Airlangga and PT Biotis Pharmaceutical Indonesia, the first phase of preclinical testing has been completed.
“Now the second stage of pre-clinical trials on Macaca animals is being carried out, the implementation of clinical trials on humans will also begin in the near future,” he said in a Hearing Meeting with Commission VII, DPR RI, Wednesday (15/9/2021).
With this achievement, he hopes that in January 2022 the clinical trial process can enter phase three. Furthermore, it can enter the registration stage, scale up mass production, to commercial.
Referring to the roadmap displayed by Khayam, the manufacture of this red and white vaccine went through several stages. First, in the first quarter of 2021, upscaling the prototype, then in the second quarter of 2021 it will enter the realm of pre-clinical testing.
Next quarter III-IV 2021, entering a clinical trial that includes three phases, at this stage assistance and submission of EUA BPOM are also carried out. Then, in quarter II-IV 2022, it will enter the registration stage, followed by scale-up of mass production in the fourth quarter of 2022, and is expected to lead to the commercial sector.
In the development of this red and white vaccine using virus isolates from Indonesia. This means that the process of making vaccine seeds is taken from samples in Indonesia and refers to viruses that are contagious in Indonesia.
“So it is more suitable and effective for Indonesia,” he said.
He emphasized that there were several important points in the development of this red and white vaccine. These include speed, effectiveness, and independence for a better meaning for Indonesia and to support national independence in preventing Covid-19.